Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin-Reference-Cited by-同舟云学术

Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin

Published:2016-07 Issue:7 Volume:32 Page:381-386
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung Journal of Medical Sciences

Author:

Su Pei-yuan,Yen Hsu-Heng,Hsu Yu-Chun,Wu Shun-Sheng,Kor Chew-Teng,Su Wei-Wen

Publisher

Wiley

Subject

General Medicine

Reference21 articles.

1. APASL consensus statements and management algorithms for hepatitis C virus infection;Omata;Hepatol Int,2012

2. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia;Zeuzem;J Hepatol,2006

3. Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial;Yu;Hepatology,2008

4. Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta-analysis;Moreno;J Hepatol,2010

5. EASL clinical practice guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J Hepatol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis;Journal of Clinical Medicine;2022-03-27

2. Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study;Journal of Clinical Medicine;2021-11-10

3. Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus—A Hospital-Based Experience;Journal of Clinical Medicine;2021-06-06

4. Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting;PLOS ONE;2020-08-13